Epinephrine or carbachol, alone or together with parathyroid hormone (PTH) or calcitonin, was added into the incubation of young rat tibia and cyclic AMP as well as cyclic GMP in the tissue was determined.
Anatomical studies have shown that bone is richly endowed with nerves but little is known concerning the possible role of the autonomic nervous system on bone cell activity (Ascenzi and Bell, 1972) . Epinephrine and other substances which stimulate beta-adrenergic receptors were to cause an increased cyclic AMP in rat fetal calvaria. They suggested that parathyroid hormone (PTH) and epinephrine affect adenylate cyclase through receptor sites that are distinct, because the effect of epinephrine but not that of PTH was abolished by propranolol. In a recent report employing freed bone cells (Rodan and Rodan, 1974) or adenylate cyclase preparation obtained from fetal tissue (Heersche et al., 1974) , it has been shown that the activation of adenylate cyclase by PTH is inhibited by epinephrine (Rodan and Rodan 1974) but unaffected by propranolol (Heersche et al., 1974) , whereas calcitonin activation of adenylate cyclase is inhibited by propranolol (Heersche et al., 1974) and unaffected by epinephrine (Rodan and Rodan, 1974 ). There appears to exist among these reports some inconsistency, probably reflecting a difference in material used. The tissues used in these previous studies were embryonic bone which is almost entirely woven in character (Pritchard, 1, 972) . It may be meaningful to reexamine the influence of adrenergic activity on PTH or calcitonin action using skeletal tissue of young animals which is lamellar in character (Pritchard, 1972) . In a variety of tissues, acetylcholine has been shown to induce an increased cyclic GMP.
A possible importance of this nucleotide has been emphasized especially in the regulation of cellular proliferation and differentiation (Chlapowski et al., 1975) and in the regulation of nervous function (Greengard, 1975) and secretory process (Smith and Ignarro, 1975; Christophe et al., 1976 ; Haymovitz and Scheele, 1976) . Rodan et al. (1975) measured cyclic GMP in bone of chick embryo, but no data are available on the effect of chemical mediators on the tissue levels of this cyclic nucleotide.
The present study was undertaken to examine the effects of adrenergic and cholinergic agonists on cyclic nucleotides concentration in young rat tibia in vitro, and how the well known effects of PTH and calcitonin on cyclic AMP concentrations are modified by these neurotransmitters. 
Results
Effects of epinephrine or carbachol on cyclic nucleotides in bone Fig. 1 shows the content of cyclic AMP as well as cyclic GMP in tibia incubated in vitro for 5min after the addition of various concentrations of epinephrine (Fig.  1A) and the time course of the change in the cyclic AMP content (Fig. 1B) . Cyclic AMP in the tissue showed a dose-related increase with maximum response at 10-5M epinephrine.
Increase in cyclic AMP content was readily observed 2 min after the addition of the hormone and returned to near basal value within 10 min. The content of cyclic GMP did not show any significant change.
The effect of increasing concentrations of carbachol on the tissue levels of cyclic nucleotides is shown in Fig. 2A . The effect of carbachol to increase cyclic GMP was nearly maximal within 10 min (Fig. 2B) . Even the highest concentration of carbachol did not alter the amount of cyclic AMP.
In the experiment shown in Table 1 , tibial shafts were separated into metaphysis and diaphysis, and the effects of epinephrine or carbachol on cyclic nucleotides in respective fractions were examined.
In the preparation of metaphysis, even though washed extensively, presence of remaining marrow components among the trabeculae could not be completely eliminated.
The preparation of diaphysis, however, corresponded to the osteocytic tissue preparation of Smith et al.(1973) , and was (Exp I). The absence of a reciprocal relationship between cyclic GMP and cyclic AMP was seen also in experiment in which PTH or calcitonin, either at low or high concentration, similarly elevated cyclic AMP levels in the presence of carbachol as in its absence (Exp. II). Carbachol was present at concentration sufficient to cause a maximal increase in cyclic GMP content.
Discussion
De Castro showed that nerve fibers regarded as autonomic in origin travel along with the blood vessels in growing bone, and end in contact with osteoblasts (Ascenzi and Bell, 1972) . A rich nerve supply was also demonstrated in adult bone passing either with the nutrient artery to the marrow vessels or from the periosteum to end near the bone cells (Hurrell, 1973) . Because of these anatomical findings, it is possible that nervous activity influences bone metabolism or bone growth. The fact that adrenergic and cholinergic transmitters both affect the metabolism of cyclic nucleotides in bone, as shown in the present study, may be regarded as evidence that the activities of bone cells can be directly influenced by autonomic nerves. The response detected in the preparation of diaphysis which corresponded to the osteocytic tissue preparation of Smith et al.(1973) probably indicates a direct involvement in the response of bone cells rather than contaminants such as marrow cells (Table  1) .
Though cholinergic stimulation has been shown to increase cyclic. GMP content in a number of tissues, the present study is the first to specifically examined its effect on bone. The carbachol induced increase shown in the present study and a pressureinduced decrease of cyclic GMP found previously by Rodan et al.(1975) in bone of chick embryo may indicate an involvement of cyclic GMP in the conveyance of nervous as well as mechanical stimuli to bone cells. In many tissues in which the action of carbachol has been studied, exclusion of calcium from incubation media has been shown to abolish this action of carbachol. The failure to show a dependency of carbachol effect on calcium by using calcium depleted medium (Table 2) may be due to the released calcium from the calcified bone fragments during the incubation.
The antagonistic action of tetracaine, however, indicates an important role of calcium in carbachol action also on bone cells. The negative effect of a divalent cation ionophore A 23187 on bone cyclic GMP in the present study may not deny a possible significance of calcium on cyclic GMP metabolism, as the calcified tissue used may bind the ionophore extracellul_arly and limit the access of this agent to cell membrane.
The mechanism by which NaN3 stimulates guanylate cyclase and the accumulation of cyclic GMP in various tissues is currently being investigated in several laboratories (DeRubertis and Craven, 1976a; Kimura et al., 1975 and . The demonstration that NaN3 causes an increase in the cyclic GMP content of bone indicates that the tissue shares at least some charateristics in common with those in tissues such as brain, liver and kidney.
In the present study, a special attention was paid to know whether the adrenergic stimulation modifies the effect of PTH or calcitonin on cyclic AMP metabolism in bone. In contrary to the findings obtained in fetal bone (Rodan and Rodan, 1974; Heersche et al., 1974) suggesting an interaction between adrenergic stimulation and PTH or calcitonin action, the data shown in Table 3 are interpreted to indicate that the regulation of cyclic AMP by these hormones is through mechanism independent of adrenergic activity.
Although studies in some tissues have shown that stimuli which increase either cyclic GMP or cyclic AMP reduce basal level as well as the response to appropriate stimuli of the other nucleotide (Lee et al., 1972; Van Sande et al., 1975; Butcher, 1975; Kuo and Kuo, 1973; Matsuzawa and Nirenberg, 1975) , such a reciprocal relationship was not demonstrated in bone under the experimental condition employed (Table 4) . To clarify whether such an absence of interaction means a difference in cell type responding to each agonist, experiment using homogenous cell population as was used by Wong and Cohn (1975) should be carried out.
Further study seems to us meaningful whether the change in the activity of adrenergic or cholinergic receptor shown to exist and to modify the levels of cyclic nucleotides in bone has any physiological role in the regulation of bone mineral metabolism.
